Renal Denervation Treatment Market
Renal Denervation Treatment Market Scope: Industry Analysis, Market Size, Growth, Trends Till
Request Sample Report
Renal Denervation Treatment Market Size and Growth
The Renal Denervation Treatment market is experiencing significant growth, driven by rising hypertension prevalence and technological advancements. The global market size is estimated to reach approximately $1.5 billion by 2028, with increasing adoption in Europe and North America. Competitive landscapes are evolving, emphasizing innovation and regulatory support for new devices.
Companies Covered
(Covid 19 Impact Covered)
◍ Abbott
◍ ReCor Medical
◍ Boston Scientific
◍ Cardiosonic
◍ Medtronic
◍ Kona medical
◍ Mercator Medsystems
◍ Terumo Corporation
◍ Abbott Laboratories
◍ Theragenics Corporation
The renal denervation treatment market includes key players like Abbott, ReCor Medical, and Medtronic, each developing innovative devices for hypertension management. These companies enhance market growth through advanced technologies, strategic partnerships, and clinical trials. Estimated sales revenues: Abbott ($10 billion+), Boston Scientific ($11.5 billion), Medtronic ($30 billion).
Request Sample Report
Market Segmentation
By Application
Hospitals
Ambulatory Surgical Centers
Others
Request Sample Report
By Product
Radiofrequency
Ultrasound
Market Growth
Request Sample Report
$ 611.81 Million
